ALFA Finder| Revenue growth | 23% YoY for FY26 to ₹3,136 million. |
|---|---|
| Margins | Mature centres at 36-37%; overall FY26 EBITDA margin at 31.8%. |
| Demand visibility | Expanding into Genomics and acquiring Fetomat to drive specialized demand. |
| Management confidence | High, citing successful ramp-up of new centres and 36-37% mature margins. |
Growth
FY26 Revenue grew 23% YoY to ₹3,136M; Q4 EBITDA rose 26% YoY to ₹252M.
Outlook
Expansion plans for FY27 include 6 new hubs and 8 spokes across Bihar, Tripura, West Bengal, and Jharkhand.
Risks
Pre-operative expenses from 20 new centres impacting near-term margins; geographical concentration in West Bengal (95.5%).
Earnings Call filed with BSE, NSE: SURAKSHA. Summary written with AI assistance from the document.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹357.85
- Market cap
- ₹1,864 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 44.6×Sector 54.5×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Results Update
Suraksha Diagnostic reported H1 FY27 total income of ₹1,893.09 million and PAT of ₹277.96 million, up 54% year-on-year. The press release accompanies its unaudited quarterly results.
Suraksha Diagnostic Q2 FY27 Results: Net Profit ₹15 Cr, Up 70.5% YoY
Suraksha Diagnostic Ltd reported revenue from operations of ₹99.1 Cr (+25.9% YoY) and net profit of ₹15 Cr (+70.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15 Cr · +70.5% YoY
Suraksha Diagnostic Board Meeting Date
Suraksha Diagnostic will hold a board meeting on 10 November 2026 to consider September quarter results and other business. Trading window closes from 1 October to 12 November 2026.
Suraksha Diagnostic Other Announcement
Suraksha Diagnostic notified that RTA KFin Technologies is moving its corporate office to Kokapet, Hyderabad from 1 December 2026, with the registered office unchanged. The change is administrative and affects only the RTA's correspondence address.
Suraksha Diagnostic Legal & Regulatory
Suraksha Diagnostic disclosed a one-day delay in shareholding pattern filing, leading to a Rs. 2,360 fine. The Board has noted remedial measures to prevent future recurrence.
Suraksha Diagnostic Management Change
Suraksha Diagnostic has appointed Ms. Shreya Arora as Company Secretary and Compliance Officer, effective October 14, 2026.